Yes. If it is authorized, it depends on the specific amino acid sequence it protects. If the sequence that has been patented does conflict with our pre-production, continuing to produce it will constitute infringement. If the sequence that we have pre-produced is inconsistent with the sequence that has been patented, If there is no conflict, it can be used.